Our CSO, Ian Wilkinson, will be presenting on the importance of attenuating effector functions in therapeutics antibodies as part of the Antibody Discovery & Development webinar series being run by The Antibody Society. The event will be held on 28th April and is free to attend. To attend please sign up here. In this webinar Ian will present data demonstrating the importance of Fc silencing, why not all mutations work equally well and up to date data on mAbsolve’s proprietary STR silencing mutations.
